The role of protein kinase C in regulation of TCDD-mediated CYP1A1 gene expression

Toxicological Sciences

Volumn 87, Issue 1, 2005, Pages 27-37

  Machemer, Daniel E W ^a   Tukey, Robert H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cytochrome P450 1A1; Gene expression; Protein kinase C; Regulation; Signal transduction

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 [1 (3 DIMETHYLAMINOPROPYL) 5 METHOXY 1H INDOL 3 YL] 3 (1H INDOL 3 YL)MALEIMIDE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; CYTOCHROME P450 1A1; HALOGENATED HYDROCARBON; ISOENZYME; LUCIFERASE; PHORBOL ESTER; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; STAUROSPORINE; XENOBIOTIC AGENT;

ARTICLE; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN CONTENT; SIGNAL TRANSDUCTION; TOXICOKINETICS;

CELL LINE, TUMOR; CYTOCHROME P-450 CYP1A1; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; TETRACHLORODIBENZODIOXIN;

EID: 24044496560     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfi220     Document Type: Article

References (51)

1. Akimoto, K., Mizuno, K., Osada, S., Hirai, S., Tanuma, S., Suzuki, K., and Ohno, S. (1994). A new member of the third class in the protein kinase C family, PKC lambda, expressed dominantly in an undifferentiated mouse embryonal carcinoma cell line and also in many tissues and cells. J. Biol. Chem. 269, 12677-12683.
2. Andrieux, L., Langouet, S., Fautrel, A., Ezan, F., Krauser, J. A., Savouret, J. F., Guengerich, F. P., Baffet, G., and Guillouzo, A. (2004). Aryl hydrocarbon receptor activation and cytochrome P450 1A induction by the mitogen-activated protein kinase inhibitor U0126 in hepatocytes. Mol. Pharmacol. 65, 934-943.
3. Berghard, A., Gradin, K., Pongratz, I., Whitelaw, M., and Poellinger, L. (1993). Cross-coupling of signal transduction pathways: The dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol. Cell Biol. 13, 677-689.
4. Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
5. Brandlin, I., Hubner, S., Eiseler, T., Martinez-Moya, M., Horschinek, A., Hausser, A., Link, G., Rupp, S., Storz, P., Pfizenmaier, K. et al. (2002). Protein kinase C (PKC)eta-mediated PKC mu activation modulates ERK and JNK signal pathways. J. Biol. Chem. 277, 6490-6496.
6. Buchner, K. (2000). The role of protein kinase C in the regulation of cell growth and in signalling to the cell nucleus. J. Cancer Res. Clin. Oncol. 126, 1-11.
7. Carrier, F., Owens, R. A., Nebert, D. W., and Puga, A. (1992). Dioxin-dependent activation of murine Cyp1a-1 gene transcription requires protein kinase C-dependent phosphorylation. Mol. Cell Biol. 12, 1856-1863.
8. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U., and Nishizuka, Y. (1982). Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters. J. Biol. Chem. 257, 7847-7851.
9. Chen, Y. H., and Tukey, R. H. (1996). Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271, 26261-26266.
10. 2+-independent protein kinase C isoforms may modulate parietal cell HCl secretion. Am. J. Physiol. 272, G246-G256.
11. Denison, M. S., Fisher, J. M., and Whitlock, Jr., J. P. (1988a). Inducible, receptor-dependent protein-DNA interactions at a dioxin-responsive transcriptional enhancer. Proc. Natl. Acad. Sci. U. S. A. 85, 2528-2532.
12. Denison, M. S., Fisher, J. M., and Whitlock, Jr. J. P., (1988b). The DNA recognition site for the dioxin-Ah receptor complex. Nucleotide sequence and functional analysis. J. Biol. Chem. 263, 17221-17224.
13. Fujita-Yamaguchi, Y., and Kathuria, S. (1988). Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor. Biochem. Biophys. Res. Commun. 157, 955-962.
14. Gadbois, D. M., Hamaguchi, J. R., Swank, R. A., and Bradbury, E. M. (1992). Staurosporine is a potent inhibitor of P34cdc2 and P34cdc2-like kinases. Biochem. Biophys. Res. Commun. 184, 80-85.
15. Gschwendt, M., Dieterich, S., Rennecke, J., Kittstein, W., Mueller, H. J., and Johannes, F. J. (1996). Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett. 392, 77-80.
16. Harper, P. A., Prokipcak, R. D., Bush, L. E., Golas, C. L., and Okey, A. B. (1991). Detection and characterization of the Ah receptor for 2,3,7,8-tetrachlorodibenzo-p-dioxin in the human colon adenocarcinoma cell line LS180. Arch. Biochem. Biophys. 290, 27-36.
17. Hausser, A., Storz, P., Hubner, S., Braendlin, I., Martinez-Moya, M., Link, G., and Johannes, F. J. (2001). Protein kinase C mu selectively activates the mitogen-activated protein kinase (MAPK) P42 pathway. FEBS Lett. 492, 39-44.
18. Hoffman, E. C., Reyes, H., Chu, F. F., Sander, F., Conley, L. H., Brooks, B. A., and Hankinson, O. (1991). Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 252, 954-958.
19. IARC (International Agency for Reaserach on Cancer). (1997). IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Polychlorinated Dibenzo-Para-Dioxins and Polychlorinated Dibenzofurans. Lyon, France, 4-11 February 1997. IARC Monogr. Eval. Carcinog. Risks Hum. 69, 1-631.
20. Ikuta, T., Kobayashi, Y., and Kawajiri, K. (2004). Phosphorylation of nuclear localization signal inhibits the ligand-dependent nuclear import of aryl hydrocarbon receptor. Biochem. Biophys. Res. Commun. 317, 545-550.
21. Johannes, F. J., Prestle, J., Eis, S., Oberhagemann, P., and Pfizenmaier, K. (1994). PKCu is a novel, atypical member of the protein kinase C family. J. Biol. Chem. 269, 6140-6148.
22. Kishimoto, A., Takai, Y., Mori, T., Kikkawa, U., and Nishizuka, Y. (1980). Activation of calcium and phospholipid-dependent protein kinase by diacylglycerol, its possible relation to phosphatidylinositol turnover. J. Biol. Chem. 255, 2273-2276.
23. Konno, Y., Ohno, S., Akita, Y., Kawasaki, H., and Suzuki, K. (1989). Enzymatic properties of a novel phorbol ester receptor/protein kinase, NPKC. J. Biochem. (Tokyo) 106, 673-678.
24. Long, W. P., and Perdew, G. H. (1999). Lack of an absolute requirement for the native aryl hydrocarbon receptor (AhR) and AhR nuclear translocator transactivation domains in protein kinase C-mediated modulation of the AhR pathway. Arch. Biochem. Biophys. 371, 246-259.
25. Long, W. P., Pray-Grant, M., Tsai, J. C., and Perdew, G. H. (1998). Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53, 691-700.
26. Mahon, M. J., and Gasiewicz, T. A. (1995). Ah receptor phosphorylation: Localization of phosphorylation sites to the C-terminal half of the protein. Arch. Biochem. Biophys. 318, 166-174.
27. Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marme, D., and Schachtele, C. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 9194-9197.
28. Meyer, B. K., and Perdew, G. H. (1999). Characterization of the AhR-Hsp90-XAP2 core complex and the role of the immunophilin-related protein XAP2 in AhR stabilization. Biochemistry 38, 8907-8917.
29. Miller, A. G., Israel, D., and Whitlock, Jr., J. P. (1983). Biochemical and genetic analysis of variant mouse hepatoma cells defective in the induction of benzo(a)pyrene-metabolizing enzyme activity. J. Biol. Chem. 258, 3523-3527.
30. Mizuno, K., Noda, K., Ueda, Y., Hanaki, H., Saido, T. C., Ikuta, T., Kuroki, T., Tamaoki, T., Hirai, S., Osada, S. (1995). UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily. FEBS Lett. 359, 259-261.
31. Mizuno, K., Saido, T. C., Ohno, S., Tamaoki, T., and Suzuki, K. (1993). Staurosporine-related compounds, K252a and UCN-01, inhibit both CPKC and NPKC. FEBS Lett. 330, 114-116.
32. Motulsky, H., and Christopoulos, A. (2004). Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting. Oxford University Press, New York.
33. Niggli, V., and Keller, H. (1991). On the role of protein kinases in regulating neutrophil actin association with the cytoskeleton. J. Biol. Chem. 266, 7927-7932.
34. Ohno, S., Akita, Y., Konno, Y., Imajoh, S., and Suzuki, K. (1988). A novel phorbol ester receptor/protein kinase, NPKC, distantly related to the protein kinase C family. Cell 53, 731-741.
35. Poland, A., and Kende, A. (1976). 2,3,7,8-Tetrachlorodibenzo-p dioxin - Environmental contaminant and molecular probe. Federation Proc. 35, 2404-2411.
36. Pongratz, I., Stromstedt, P. E., Mason, G. G., and Poellinger, L. (1991). Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266, 16813-16817.
37. Postlind, H., Vu, T. P., Tukey, R. H., and Quattrochi, L. C. (1993). Response of human CYP1-luciferase plasmids to 2,3,7,8-tetrachlorodibenzo-p-dioxin and polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 118, 255-262.
38. Reyes, H., Reisz-Porszasz, S., and Hankinson, O. (1992). Identification of the Ah receptor nuclear translocator protein (Arnt) as a component of the DNA binding form of the Ah receptor. Science 256, 1193-1195.
39. Safe, S.,Wang, F., Porter,W., Duan, R., and McDougal, A. (1998). Ah receptor agonists as endocrine disruptors: Antiestrogenic activity and mechanisms. Toxicol. Lett. 102-103, 343-347.
40. Schafer,M.W., Madhukar, B. V., Swanson, H. I., Tullis, K., and Denison, M. S. (1993). Protein kinase C is not involved in Ah receptor transformation and DNA binding. Arch. Biochem. Biophys. 307, 267-271.
41. Schweer, G., and Jennings, P. (1990). Integrated Risk Assessment for Dioxins and Furans from Chlorine Bleaching in Pulp and Paper Mills. PB91-102087, 1-98. Springfield, VA, National Technical Information Service.
42. Simpson, J., Johnson, M. S., and Mitchell, R. (1993). H7-resistant protein kinase C substrates in two-dimensional gels of proestrous rat anterior pituitary gland. Biochim. Biophys. Acta 1220, 69-75.
43. Singh, S. S., and Perdew, G. H. (1993). Alterations in the Ah receptor level after staurosporine treatment. Arch. Biochem. Biophys. 305, 170-175.
44. Steenland, K., Bertazzi, P., Baccarelli, A., and Kogevinas, M. (2004). Dioxin revisited: Developments since the 1997 IARC classification of dioxin as a human carcinogen. Environ. Health Perspect. 112, 1265-1268.
45. Tan, Z., Huang, M., Puga, A., and Xia, Y. (2004). A critical role for MAP kinases in the control of Ah receptor complex activity. Toxicol. Sci. 82, 80-87.
46. Viel, J. F., Arveux, P., Baverel, J., and Cahn, J. Y. (2000). Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am. J. Epidemiol. 152, 13-19.
47. Ways, D. K., Cook, P. P.,Webster, C., and Parker, P. J. (1992). Effect of phorbol esters on protein kinase C-zeta. J. Biol. Chem. 267, 4799-4805.
48. Weber, T. J., Ou, X., Merchant, M., Wang, X., Safe, S. H., and Ramos, K. S. (1994). Biphasic modulation of protein kinase C (PKC) activity by polychlorinated dibenzo-p-dioxins (PCDDs) in serum-deprived rat aortic smooth muscle cells. J. Biochem. Toxicol. 9, 113-120.
49. Wilson, C. L., and Safe, S. (1998). Mechanisms of ligand-induced aryl hydrocarbon receptor-mediated biochemical and toxic responses. Toxicol. Pathol. 26, 657-671.
50. Wisdom, R. (1999). AP-1: One switch for many signals. Exp. Cell Res. 253, 180-185.
51. Yim, S., Oh, M., Choi, S. M., and Park, H. (2004). Inhibition of the MEK-1/P42 MAP kinase reduces aryl hydrocarbon receptor-DNA interactions. Biochem. Biophys. Res. Commun. 322, 9-16.